Text Size
36 studies found for:    " January 21, 2009":" February 20, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" January 21, 2009":" February 20, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Video-based Counseling & Rapid HIV Testing for Teens
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Video;   Behavioral: in-person HIV pre-test counseling
2 Unknown † Positive Lifestyles Using Safety
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Pre-Release (Group 1);   Behavioral: Post-release (Group 2)
3 Active, not recruiting
Has Results 		Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Interactive injection and sexual risk intervention;   Behavioral: Interactive Sexual Risk Intervention;   Behavioral: Interactive Injection Risk Intervention
4 Unknown † A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication
Conditions: HIV-1;   HIV Infections
Interventions: Other: VircoType HIV-1 genotypic interpretation;   Other: Local Expert Review of HIV Genotypic resistance testing
5 Unknown † Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men
Conditions: HIV Infection;   Cardiovascular Risk;   HIV Infections
Interventions: Other: Omega-3 study meal;   Other: Saturated fat study meal
6 Unknown † Transitions: Linkages From Jail To Community
Conditions: HIV;   Substance Abuse;   HIV Infections
Interventions: Behavioral: Intensive Case Management;   Drug: Buprenorphine;   Behavioral: Money Management
7 Completed Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV
Conditions: HIV;   HIV Infections
Interventions: Biological: ZFN modified T cells;   Other: Structured Treatment Interruption
8 Completed Acupuncture/Moxibustion (Acu/Moxa) for Distal Symmetric Peripheral Neuropathy (DSP) in HIV
Conditions: Peripheral Neuropathy;   HIV;   AIDS;   HIV Infections
Interventions: Other: Acupuncture / Moxibustion;   Other: Acupuncture/Moxibustion
9 Completed Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya
Conditions: HIV;   Malnutrition;   HIV Infections
Interventions: Dietary Supplement: fortified blended flour - Insta Foundation Plus (with whey protein concentrate);   Other: nutrition counseling
10 Completed Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: Cell Phone Intervention
11 Active, not recruiting Effect of Raltegravir on Endothelial Function in HIV-Infected Patients
Conditions: HIV Infection;   Inflammation;   Cardiovascular Disease;   HIV Infections
Interventions: Drug: raltegravir;   Drug: Placebo
12 Completed ID and Testing Via Friendship Networks
Conditions: Asymptomatic HIV;   HIV Infections
Interventions: Other: Index Recruiter;   Other: Friendship Network Member
13 Unknown † Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring
Conditions: Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Reducing dose of Lopinavir;   Drug: Reducing dose of efavirenz
14 Active, not recruiting Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension
Conditions: HIV Infection;   Pulmonary Hypertension;   Endothelial Function;   HIV Infections
Intervention:
15 Completed A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)(COMPLETED)
Conditions: HIV-1;   HIV Infections
Interventions: Biological: V520;   Biological: Comparator: V520 (1x10^9 vp/d);   Biological: Comparator: V520 (1x10^10 vp/d);   Biological: Comparator: Placebo
16 Completed
Has Results 		A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)
Conditions: HIV-1;   HIV Infections
Interventions: Other: Comparator: Placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine;   Biological: Monovalent MRKAd5 HIV-1 gag vaccine (1x10^9 vp/dose);   Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^6 vp/dose);   Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^7 vp/dose);   Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^8 vp/dose);   Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^9 vp/dose);   Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^10 vp/dose);   Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10^11 vp/dose);   Biological: Comparator: Placebo to MRKAd5 HIV-1 gag vaccine
17 Active, not recruiting A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Biological: mRNA-transfected autologous dendritic cells;   Biological: Autologous dendritic cells not transfected with mRNA.
18 Unknown † An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users
Conditions: Using Cocaine or Heroin in the Last 7 Days,;   Age Over 18 Years Old,;   Competent to Sign Informed Consent for HIV/HBV/HCV Testing,;   HIV/HBV Negatives Will be Randomized for HB Vaccine Study;   HIV Infections
Interventions: Biological: hepatitis B vaccine schedule;   Behavioral: HBV Vaccination Self-Efficacy Intervention
19 Active, not recruiting Treatment of Acute Hepatitis C Virus in HIV Co-Infection
Conditions: Hepatitis C Virus;   Human Immunodeficiency Virus;   HIV Infections
Intervention: Drug: Pegylated interferon alfa-2a + Ribavirin
20 Completed
Has Results 		Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants
Conditions: Human Immunodeficiency Virus Type 1 (HIV-1);   HIV Infections
Interventions: Drug: Voriconazole;   Drug: Atazanavir;   Drug: Ritonavir
To Top

Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results
† Indicates status has not been verified in more than two years